drugset / Trial / NCT04031859
Risk Stratification Procedure for Thromboembolism Prophylaxis
Phase 2
Completed
242 enrolled
Ministry of Health, Saudi Arabia
Prince Sultan Military College of Health Sciences · collabUniversiti Sains Malaysia · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The main objective for this study is validation for the proposed risk stratification tool, by evaluating the clinical outcomes for its use post TKR Surgeries. For this objective, the design that is used is Randomized Trial.
Timeline
- Start
- 2018-10-10
- Primary completion
- 2019-07-14
- Completion
- 2019-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Aspirin | Small molecule | — | — |
Indications
No indication recorded.